At its first meeting under the new administration, the US Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted on recommendations for several ...

Ziresovir is the first antiviral to demonstrate significant clinical efficacy and long-term respiratory benefits in ...

Ziresovir's Phase III results mark a significant milestone, representing the first clinical validation of an antiviral's ...

Researchers from the Wesfarmers Center of Vaccines and Infectious Diseases, based at The Kids Research Institute Australia, ...

Common respiratory condition nearly triples the risk of death in adults, new study finds A major study presented today at ...